Komori
Tsubakimoto Chain Co. (6371) · InitiativeAdvanced

Development of new products and technologies based on technological capabilities

First written in FY2016. 24 of 34 entries say "Restated". Latest entry: FY2026.

34entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q3RestatedFY2019-Q1 – FY2020-Q3RestatedFY2021-Q2 – FY2022-Q3RestatedFY2024-Q1 – FY2025-H12016: 320162017: 320172018: 320182019: 420192020: 420202021: 320212022: 420222023: 420232024: 220242025: 220252026: 22026
Same theme, other companies

113 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 245 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Group has approximately 600 R&D staff, representing approximately 5% of total employees.」

    R&D staff increased from approximately 500 to approximately 600, and R&D expenses also increased to ¥8,089 million. Cooperation with external institutions and the development of new products and technologies in each business also continued.
  2. 2026-05-29AdvancedGeneral Meeting of Shareholders

    「In the Mobility business, we will expand our market share by increasing sales of timing chain systems and optimize global production by reorganizing and consolidating sites in Japan and overseas, making use of integration synergies with Daido Kogyo Co., Ltd.」

    The integration with Daido Kogyo is being linked to the reorganization and consolidation of domestic and overseas sites and global production optimization.
  3. FY2026-H1RestatedAnnual report

    「The group’s total research and development expenses for the current interim consolidated accounting period were ¥3,396 million. There were no material changes in the status of the group’s research and development activities during the current interim consolidated accounting period.」

    The Company states that there have been no material changes in its R&D activities and discloses R&D expenses of ¥3,396 million for the current interim consolidated period.
  4. FY2025AdvancedAnnual report

    「The Group has approximately 500 R&D staff, representing approximately 6% of total employees. … Total R&D expenses for the current consolidated fiscal year were ¥6,820 million, including ¥1,047 million in corporate expenses not allocated to any reportable segment.」

    The Group has approximately 500 R&D staff, representing approximately 6% of total employees, and R&D expenses were ¥6,820 million. R&D scale and expenses increased from approximately 480 staff, approximately 6% of total employees, and ¥5,696 million in the previous fiscal year.
  5. FY2025-H1RestatedAnnual report

    「The amount of the Group's research and development activities during the interim consolidated accounting period was ¥3,359 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」

    The Company states that there have been no material changes in its R&D activities and reports R&D expenses of ¥3,359 million.
  6. FY2024-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the nine-month period ended the third quarter was ¥4,624 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」

    The Company reports R&D expenses of ¥4,624 million and states that there have been no material changes in its R&D activities, continuing its existing R&D structure and policy.
  7. FY2024-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the six-month period ended the second quarter was ¥3,024 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」

    The Company states that there have been no material changes in its R&D activities and discloses cumulative second-quarter R&D expenses of ¥3,024 million.
  8. FY2024-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the three-month period ended the first quarter was ¥1,507 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」

    The Company discloses quarterly R&D expenses of ¥1,507 million, stating that there have been no material changes in its R&D activities.
  9. FY2023AdvancedAnnual report

    「The Group has approximately 480 R&D staff, representing approximately 6% of total employees. … Total R&D expenses for the current consolidated fiscal year were ¥5,696 million, including ¥749 million in corporate expenses not allocated to any reportable segment.」

    R&D staff increased from approximately 440, or approximately 5%, to approximately 480, or approximately 6%, and R&D expenses increased from ¥5,199 million to ¥5,696 million. Cooperation with universities and other external institutions also continued.
  10. FY2023-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the nine-month period ended the third quarter was ¥4,113 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」

    The Company reports R&D expenses of ¥4,113 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  11. FY2023-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the six-month period ended the second quarter was ¥2,637 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」

    The Company reports R&D expenses of ¥2,637 million and states that there have been no material changes in its R&D activities.
  12. FY2023-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the three-month period ended the first quarter was ¥1,292 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」

    The Company reports R&D expenses of ¥1,292 million and states that there have been no material changes in its R&D activities, continuing its existing R&D structure and policy.
  13. FY2022AdvancedAnnual report

    「The Group has approximately 440 R&D staff, representing approximately 5% of total employees. The Company also maintains close cooperative relationships with external institutions, including Kyoto University, the University of Tokyo, Tohoku University and Hokkaido University, enabling it to pursue research and development of advanced technologies effectively. Total R&D expenses for the current consolidated fiscal year were ¥5,199 million, including ¥669 million in corporate expenses not allocated to any reportable segment.」

    R&D staff increased to approximately 440, from approximately 400 in the previous fiscal year, representing approximately 5% of total employees. R&D expenses also increased to ¥5,199 million, while cooperation with universities and other external institutions continued.
  14. FY2022-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the nine-month period ended the third quarter was ¥3,777 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」

    The Company reports R&D expenses of ¥3,777 million and states that there have been no material changes in its R&D activities, continuing its existing R&D structure and policy.
  15. FY2022-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the six-month period ended the second quarter was ¥2,469 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」

    The Company reports R&D expenses of ¥2,469 million and states that there have been no material changes in its R&D activities, continuing its existing R&D structure and policy.
  16. FY2021RestatedAnnual report

    「Research and development is carried out by the Company's technology and R&D department, the technology and production engineering departments of each business division, and the design and development departments of each affiliated company. The Group has approximately 400 R&D staff, representing approximately 5% of total employees. The Company also maintains close cooperative relationships with external institutions, including Kyoto University, the University of Tokyo, Tohoku University and Hokkaido University, enabling it to pursue research and development of advanced technologies effectively.」

    The Company continues its structure of approximately 400 R&D staff, representing approximately 5% of total employees, and cooperation with universities and other institutions. R&D expenses for the current fiscal year were ¥4,288 million.
  17. FY2021-Q3RestatedAnnual report

    「R&D expenses for the Group during the cumulative third-quarter period were ¥3,157 million. As of 1 April 2020, the Development and Technology Center was divided into New Business Development and Technology and R&D to increase the flexibility of new business and R&D.」

    The Company reports R&D expenses of ¥3,157 million and continues the R&D structure resulting from the division of the Development and Technology Center as of 1 April 2020.
  18. FY2021-Q2RestatedAnnual report

    「R&D expenses for the Group during the cumulative second-quarter period were ¥2,087 million. As of 1 April 2020, the Development and Technology Center was divided into New Business Development and Technology and R&D to increase the flexibility of new business and R&D.」

    The Company reports R&D expenses of ¥2,087 million and continues the R&D structure resulting from the division of the Development and Technology Center as of 1 April 2020.
  19. FY2021-Q1AdvancedAnnual report

    「R&D expenses for the Group during the cumulative first-quarter period were ¥1,045 million. As of 1 April 2020, the Development and Technology Center was divided into New Business Development and Technology and R&D to increase the flexibility of new business and R&D.」

    In addition to reporting R&D expenses of ¥1,045 million, the Company divided the Development and Technology Center into the New Business Development Division and the Technology and R&D Division as of 1 April 2020, changing its structure to increase the flexibility of new business and R&D.
  20. FY2020AdvancedAnnual report

    「The Group has approximately 400 R&D staff, representing approximately 5% of total employees. The Company also maintains close cooperative relationships with external institutions, including Kyoto University, the University of Tokyo, Chiba University and Nagoya University, enabling it to pursue research and development of advanced technologies effectively.」

    R&D staff increased to approximately 400, or approximately 5% of total employees, from approximately 350, or approximately 4%, in FY2019. R&D expenses also increased to ¥4,714 million.
  21. FY2020-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the nine-month period ended the third quarter was ¥3,533 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」

    The Company reports R&D expenses of ¥3,533 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  22. FY2020-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the six-month period ended the second quarter was ¥2,408 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」

    The Company reports R&D expenses of ¥2,408 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  23. FY2020-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the three-month period ended the first quarter was ¥1,167 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」

    The Company reports R&D expenses of ¥1,167 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  24. FY2019Update to R&D staff sizeAnnual report

    「Research and development is currently carried out by the Company's Development and Technology Center, the technology and production engineering departments of each business division, and the design and development departments of each affiliated company. The Group has approximately 350 R&D staff, representing approximately 4% of total employees. The Company also maintains close cooperative relationships with external institutions, including Kyoto University, the University of Tokyo, Chiba University and Nagoya University, enabling it to pursue research and development of advanced technologies effectively.」

    The Company maintains its R&D structure and cooperation with external institutions, and reports approximately 350 R&D staff, representing approximately 4% of total employees. R&D expenses were ¥4,505 million.
  25. FY2019-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the nine-month period ended the third quarter was ¥3,369 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」

    The Company reports R&D expenses of ¥3,369 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  26. FY2019-Q1RestatedAnnual report

    「The Group's research and development expenditure for the first quarter of the current fiscal year was ¥1,212 million. There were no material changes in the status of the Group's research and development activities during the first quarter.」

    The Company reports R&D expenses of ¥1,212 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  27. FY2018AdvancedAnnual report

    「Research and development is carried out by the Company's Development and Technology Center, the technology and production engineering departments of each business division, and the design and development departments of each affiliated company. The Group has approximately 370 R&D staff, representing approximately 4% of total employees. The Company also maintains close cooperative relationships with external institutions, including Kyoto University, the University of Tokyo, Chiba University and Doshisha University, enabling it to pursue research and development of advanced technologies effectively. Total R&D expenses for the current consolidated fiscal year were ¥4,495 million, including ¥359 million in corporate expenses not allocated to any reportable segment.」

    The Group has approximately 370 R&D staff, representing approximately 4% of total employees, and R&D expenses for the current fiscal year were ¥4,495 million. The scale and results of activities have been specified while maintaining the existing structure.
  28. FY2018-Q3RestatedAnnual report

    「The Group's research and development expenditure for the nine months ended the third quarter of the current fiscal year was ¥3,321 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」

    The Company reports R&D expenses of ¥3,321 million and states that there have been no material changes in its R&D activities, continuing its existing structure and policy.
  29. FY2018-Q2RestatedAnnual report

    「The Group's research and development expenditure for the six months ended the second quarter of the current fiscal year was ¥2,218 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」

    The Company reports R&D expenses of ¥2,218 million and states that there have been no material changes in its R&D activities, continuing its existing R&D structure and policy.
  30. FY2018-Q1RestatedAnnual report

    「The Group's research and development expenditure for the first quarter of the current fiscal year was ¥1,095 million. There were no material changes in the status of the Group's research and development activities during the first quarter.」

    The Company states that there have been no material changes in R&D activities and reports R&D expenses of ¥1,095 million for FY2018-Q1.
  31. FY2017-Q3RestatedAnnual report

    「The Group's research and development expenditure for the nine months ended the third quarter of the current fiscal year was ¥3,200 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」

    The Company states that there have been no material changes in R&D activities and reports R&D expenses of ¥3,200 million for the cumulative third-quarter period.
  32. FY2017-Q2RestatedAnnual report

    「The Group's research and development expenditure for the six months ended the second quarter of the current fiscal year was ¥2,162 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」

    The Company states that there have been no material changes in R&D activities and reports R&D expenses of ¥2,162 million for the cumulative period of the current quarter.
  33. FY2017-Q1RestatedAnnual report

    「The company states that there were no material changes in its research and development activities during the first quarter of the current fiscal year and reports R&D expenditure of ¥1,084 million for the period.」

    The company states that there were no material changes in its research and development activities and reports R&D expenditure of ¥1,084 million for the quarter.
  34. FY2016First statedAnnual report

    「Research and development is currently carried out by the Company's Development and Technology Center, the technology and production engineering departments of each business division, and the design and development departments of each affiliated company. The Group has approximately 310 R&D staff, representing approximately 4% of total employees. The Company also maintains close cooperative relationships with external institutions, including the University of Tokyo and Doshisha University, enabling it to pursue research and development of advanced technologies effectively.」

    The R&D structure, staff size and cooperation with external institutions are described in specific terms.
Moved together

"Expanding, rationalizing and renewing production facilities" moved the same way as this thread, in the same document, in 5 of its 34 moves.

544433★123456
  1. ★This thread
  2. 1Expanding, rationalizing and renewing production facilities5×
  3. 2FY2020 Revenue of ¥300 Billion, Operating Margin of 10%, and Overseas Revenue Ratio of 70%4×
  4. 3Identification, assessment and prevention of risks4×
  5. 4Reviewing the Rationale for Strategic Shareholdings Held to Strengthen Business Relationships4×
  6. 5Strengthening Earnings Power3×
  7. 6Flexible Capital Policy Through Share Repurchases3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tsubakimoto Chain Co. yet. It last moved in the General Meeting of Shareholders of 2026-05-29: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of new products and technologies based on technological capabilities | TSUBAKIMOTO CHAIN CO. (6371) | Komori